Activation of Stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated Src and survivin expression

被引:205
作者
Diaz, N
Minton, S
Cox, C
Bowman, T
Gritsko, T
Garcia, R
Eweis, I
Wloch, M
Livingston, S
Seijo, E
Cantor, A
Lee, JH
Beam, CA
Sullivan, D
Jove, R
Muro-Cacho, CA
机构
[1] Univ S Florida, Coll Med, Pathol Program, Tampa, FL USA
[2] Univ S Florida, Coll Med, Comprehens Breast Canc Program, Tampa, FL USA
[3] Univ S Florida, Coll Med, Mol Oncol Program, Tampa, FL USA
[4] Univ S Florida, Coll Med, Expt Therapeut Program, H Lee Moffit Canc Ctr & Res Inst,Dept Interdiscip, Tampa, FL USA
关键词
D O I
10.1158/1078-0432.CCR-04-1749
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Constitutive activation of signal transducer and activator of transcription 3 (Stat3) protein has been observed in a wide variety of tumors, including breast cancer, and contributes to oncogenesis at least in part by prevention of apoptosis. In a study of 45 patients with high-risk breast cancer enrolled in a phase II neoadjuvant chemotherapy trial with docetaxel and doxorubicin, we evaluated the levels of Stat3 activation and potentially associated molecular biomarkers in invasive breast carcinoma compared with matched nonneoplastic tissues. Experimental Design: Using immunohistochemistry and image analysis, we quantified the levels of phospho-Stat3 (pY-Stat3), phospho-Src (pY-Src), epidermal growth factor receptor, HER2/neu, Ki-67, estrogen receptor, Bcl-2, Bcl-x(L), Survivin, and apoptosis in formalin-fixed, paraffin-embedded sections from invasive carcinomas and their paired nonneoplastic parenchyma. The levels of molecular biomarkers in nonneoplastic and tumor tissues were analyzed as continuous variables for statistically significant correlations. Results: Levels of activated pY-Stat3 and pY-Src measured by immunohistochemistry were significantly higher in invasive carcinoma than in nonneoplastic tissue (P < 0.001). In tumors, elevated levels of pY-Stat3 correlated with those of pY-Src and Survivin. Levels of pY-Stat3 were higher in partial pathologic responders than in complete pathologic responders. In partial pathologic responders, pY-Stat3 levels correlated with Survivin expression. Conclusions: Our findings suggest important roles for elevated activities of Stat3 and Src, as well as Survivin expression, in malignant progression of breast cancer. Furthermore, elevated Stat3 activity correlates inversely with complete pathologic response. These findings suggest that specific Stat3 or Src inhibitors could offer clinical benefits to patients with breast cancer.
引用
收藏
页码:20 / 28
页数:9
相关论文
共 52 条
  • [1] Alas S, 2003, CLIN CANCER RES, V9, P316
  • [2] Alas S, 2001, CANCER RES, V61, P5137
  • [3] Validating survivin as a cancer therapeutic target
    Altieri, DC
    [J]. NATURE REVIEWS CANCER, 2003, 3 (01) : 46 - 54
  • [4] Survivin and apoptosis control
    Altieri, DC
    [J]. ADVANCES IN CANCER RESEARCH, VOL 88, 2003, 88 : 31 - 52
  • [5] A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
    Ambrosini, G
    Adida, C
    Altieri, DC
    [J]. NATURE MEDICINE, 1997, 3 (08) : 917 - 921
  • [6] Early changes in apoptosis and proliferation following primary chemotherapy for breast cancer
    Archer, CD
    Parton, M
    Smith, IE
    Ellis, PA
    Salter, J
    Ashley, S
    Gui, G
    Sacks, N
    Ebbs, SR
    Allum, W
    Nasiri, N
    Dowsett, M
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (06) : 1035 - 1041
  • [7] Src family kinases and HER2 interactions in human breast cancer cell growth and survival
    Belsches-Jablonski, AP
    Biscardi, JS
    Peavy, DR
    Tice, DA
    Romney, DA
    Parsons, SJ
    [J]. ONCOGENE, 2001, 20 (12) : 1465 - 1475
  • [8] Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 International Study
    Bilous, M
    Ades, C
    Armes, J
    Bishop, J
    Brown, R
    Cooke, B
    Cummings, M
    Farshid, G
    Field, A
    Morey, A
    McKenzie, P
    Raymond, W
    Robbins, P
    Tan, L
    [J]. BREAST, 2003, 12 (02) : 92 - 98
  • [9] Tyrosine kinase signalling in breast cancer - Epidermal growth factor receptor and c-Src interactions in breast cancer
    Biscardi, JS
    Ishizawar, RC
    Silva, CM
    Parsons, SJ
    [J]. BREAST CANCER RESEARCH, 2000, 2 (03): : 203 - 210
  • [10] THE MOLECULAR-GENETICS OF CANCER
    BISHOP, JM
    [J]. SCIENCE, 1987, 235 (4786) : 305 - 311